lisinopril
NDC 43353-298, lisinopril, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 43353-298
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203508
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43353-298 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISINOPRIL5 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43353-298-30 | 43353029830 | 30 TABLET in 1 BOTTLE (43353-298-30) |
| 43353-298-45 | 43353029845 | 45 TABLET in 1 BOTTLE (43353-298-45) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/32eb18bc-a80d-4de1-8f38-e591d8f66870
Use it
Look up 43353-298 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43353-298 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43353-298. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.